ArticleBMC ophthalmology2026
Corneal endothelial morphology in type 2 diabetes mellitus, a comparative study among Nepalese population.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo access and compare the corneal endothelial morphology between type two diabetic patients (T2DM) and non-diabetic controls, and to explore their associations with diabetes duration, HbA1c levels and severity of diabetic retinopathy in a Nepalese cohort as diabetes can lead to morphological changes in the corneal endothelium, yet data specific to the Nepalese population remain limited.
methodsA hospital-based, cross-sectional, comparative study was conducted involving 220 eyes (110 diabetic and 110 control). Non-contact specular microscopy (NIDEK CEM-530) was employed to access endothelial cell parameters, including endothelial cell density (ECD), coefficient of variation (CV), percentage of hexagonal cells (HEX), and central corneal thickness (CCT).
resultsDiabetic corneas exhibited significantly lower ECD (2728.68 ± 216.40 vs. 2847.74 ± 194.97 cells/mm², p < 0.001) and HEX (64.93 ± 4.88% vs. 66.15 ± 4.09%, p = 0.0045), alongside higher CV (32.49 ± 4.26% vs. 31.01 ± 3.08%, p = 0.003) and CCT (545.63 ± 29.93 μm vs. 534.32 ± 27.29 μm, p = 0.004). Longer duration of diabetes (≥ 10 years) correlated with reduced ECD (p = 0.013). Eyes with DR demonstrated more pronounced endothelial dysfunction, (p < 0.05). HEX showed a negative correlation with HbA1c (p = 0.038).
conclusionT2DM significantly alters corneal endothelial morphology and function, with worsening changes associated with prolonged diabetes, poor glycemic control, and advanced DR. These findings underscore the need for routine endothelial evaluation in diabetic patients to mitigate surgical risks and monitor corneal health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.